[1]
Meng, Z. 2025. Long-term Safety Profile of Semaglutide in the Management of Type 2 Diabetes and Obesity. MedScien. 3, 3 (Jun. 2025), 3422. DOI:https://doi.org/10.61173/rvr8p069.